22nd Century Announces 1-for-135 Reverse Stock Split
22nd Century Announces 1-for-135 Reverse Stock Split
Mocksville, North Carolina--(Newsfile Corp. - December 13, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it will effect a reverse stock split of its outstanding shares of common stock, par value $0.00001 per share (the "Common Stock"), at a ratio of 1-for-135, to be effective as of December 17, 2024. The reverse stock split is intended for the Company to regain compliance with the minimum bid price requirement of $1.00 per share of common stock for continued listing on Nasdaq.
北卡罗莱纳州莫克斯维尔--(新闻文件公司 - 2024年12月13日) - 22世纪集团公司(纳斯达克:XXII),一家领导抗击尼古丁的烟草制品公司,认为吸烟者应该对他们的尼古丁消费有选择权,今天宣布将按照1比135的比例进行普通股的反向股票拆分,拆分将在2024年12月17日生效。反向股票拆分旨在使公司重新符合纳斯达克持续上市的普通股最低买盘价格1.00美元的要求。
Lawrence Firestone, Chief Executive Officer said, "Over the past year since joining the Company, we have made significant changes which have improved our operating model and balance sheet. We are moving quickly to activate our new VLN strategy which includes deploying private label VLN brands. We are on track to become EBITDA profitable as early as the first quarter of 2025. With our operating improvements and recent actions, we recently regained compliance with the shareholder's equity requirement, and this last step will enable us to regain compliance with the Nasdaq minimum bid price requirement as we continue to work toward creating long-term shareholder value."
首席执行官劳伦斯·火石说:“自从加入公司以来的过去一年里,我们进行了显著的变革,改善了我们的运营模式和资产负债表。我们正在迅速激活我们的新VLN策略,其中包括推出私人标签的VLN品牌。我们有望在2025年第一季度就实现EBITDA盈利。凭借我们的运营改进和最近的行动,我们最近重新符合了股东权益的要求,最后一步将使我们能够重新符合纳斯达克最低买盘价格的要求,同时我们继续致力于创造长期股东价值。”
22nd Century Common Stock will begin trading on a reverse stock split-adjusted basis at the opening of The Nasdaq Capital Market ("Nasdaq") on Tuesday, December 17, 2024. Following the reverse stock split, the Common Stock will continue to trade on Nasdaq under the symbol "XXII" with the new CUSIP number, 90137F400.
22世纪普通股将于2024年12月17日星期二在纳斯达克资本市场(“纳斯达克”)开盘时以经过反向股票拆分调整的基础进行交易。在反向股票拆分后,普通股将继续在纳斯达克交易,标的为“XXII”,新CUSIP号码为90137F400。
The reverse stock split will consolidate the number of issued and outstanding shares of the Company's common stock to approximately 504,000.
反向股票拆分将使公司普通股的已发行和流通股数合并为约504,000股。
About 22nd Century Group, Inc.
关于22nd Century Group, Inc.
22nd Century Group is the pioneering nicotine harm reduction company in the tobacco industry enabling smokers to take control of their nicotine consumption.
22世纪集团是烟草行业开创性的尼古丁伤害减轻公司,使吸烟者能够控制他们的尼古丁消费。
We created our flagship product, the VLN cigarette, to give traditional cigarette smokers an authentic and familiar alternative that helps them take control of their nicotine consumption. VLN cigarettes have 95% less nicotine than the traditional cigarette and have been proven to greatly reduce nicotine consumption. Instead of offering new ways of delivering nicotine to addicted smokers, we offer smokers the option to take control of their nicotine consumption and make informed and more productive choices, including the choice to avoid addictive levels of nicotine altogether.
我们创造了我们的旗舰产品VLN香烟,旨在为传统香烟吸烟者提供一种真实且熟悉的替代品,帮助他们控制自己的尼古丁消费。VLN香烟的尼古丁含量比传统香烟少95%,且已被证明可以大大降低尼古丁消费。我们不是提供向上瘾吸烟者递送尼古丁的新方式,而是为吸烟者提供控制尼古丁消费的选项,让他们做出知情和更加有效的选择,包括选择完全避免上瘾水平的尼古丁。
Our wholly owned subsidiaries include a leading cigarette manufacturer that produces all VLN products and provides turnkey contract manufacturing for other tobacco brands both domestically and internationally. The 60,000 square foot facility in Mocksville, North Carolina has the capacity to produce more than 45 million cartons of combusted tobacco products annually with additional space for expansion.
我们的全资子公司包括一家领先的香烟制造商,生产所有VLN产品,并为其他烟草品牌提供交钥匙合同制造,服务范围涵盖国内和国际市场。位于北卡罗来纳州莫克斯维尔的60,000平方英尺的设施每年能够生产超过4500万箱烟草制品,并有额外的扩展空间。
Our proprietary reduced nicotine tobacco blends are made possible by comprehensive and patented technologies that regulate nicotine biosynthesis activities in the tobacco plant, resulting in full flavor and high yield with 95% less nicotine. Our extensive patent portfolio has been developed to ensure we have the only low nicotine combustible cigarette in the United States and critical international markets. Our mission is to sell the last cigarette before the 22nd Century.
我们的专有低 nicotine 烟草混合物得益于全面的专利技术,这些技术调节烟草植物中的 nicotine 生物合成活动,从而实现完整的风味和高产量,同时 nicotine 减少了95%。我们的广泛专利组合旨在确保我们在美国及关键国际市场拥有唯一的低 nicotine 可燃香烟。我们的使命是在22世纪之前,卖出最后一支香烟。
VLN and Helps You Smoke Less are registered trademarks of 22nd Century Limited LLC.
VLN和降低吸烟量的Helps You Smoke Less是22nd century Limited LLC的注册商标。
Learn more at xxiicentury.com, on X (formerly Twitter), on LinkedIn, and on YouTube.
了解更多请访问 xxiicentury.com,在 X(前身为Twitter),在 LinkedIn,并且在 YouTube.
Learn more about VLN at tryvln.com.
了解更多关于VLN的信息。 tryvln.com.
Cautionary Note Regarding Forward-Looking Statements
关于前瞻性声明的警示说明
Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements, including but not limited to our full year business outlook. Forward-looking statements typically contain terms such as "anticipate," "believe," "consider," "continue," "could," "estimate," "expect," "explore," "foresee," "goal," "guidance," "intend," "likely," "may," "plan," "potential," "predict," "preliminary," "probable," "project," "promising," "seek," "should," "will," "would," and similar expressions. Forward-looking statements include, but are not limited to, statements regarding (i) our cost reduction initiatives, (ii) our expectations regarding regulatory enforcement, including our ability to receive an exemption from new regulations, (iii) our financial and operating performance and (iv) our expectations for our business interruption insurance claim. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in "Risk Factors" in the Company's Annual Report on Form 10-K filed on March 28, 2024, and in the Company's Quarterly Reports filed on May 15, 2024, August 13, 2024 and November 11, 2024. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.
除历史信息外,本新闻稿中包含的所有陈述、预期和假设均为前瞻性陈述,包括但不限于我们的全年业务展望。前瞻性陈述通常包含“预期”、“相信”、“考虑”、“继续”、“可能”、“估计”、“期待”、“探索”、“预见”、“目标”、“指导”、“打算”、“很可能”、“可能”、“计划”、“潜在”、“预测”、“初步”、“可能”、“项目”、“有前景”、“寻求”、“应该”、“将”、“会”等类似表达。前瞻性陈述包括但不限于关于(i)我们的成本削减举措,(ii)我们对监管执行的预期,包括我们获得新规豁免的能力,(iii)我们的财务和运营表现,以及(iv)我们对业务中断保险索赔的预期。实际结果可能与前瞻性陈述中明确或隐含的结果有实质性差异。可能导致实际结果与前瞻性陈述之间产生实质性差异的重要因素已在公司2024年3月28日提交的10-K表年度报告中的“风险因素”部分,以及公司在2024年5月15日、2024年8月13日和2024年11月11日提交的季度报告中列出。本文提供的所有信息均为截至本日期的信息,公司不承担任何义务,也不打算更新这些前瞻性陈述,法律要求的情况除外。
Investor Relations & Media Contact
Matt Kreps
Investor Relations
22nd Century Group
mkreps@xxiicentury.com
214-597-8200
投资者关系与媒体联系方式
马特·克雷普斯
投资者关系
22世纪集团
mkreps@xxiicentury.com
214-597-8200